University of Antwerp
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Peeters, Marc
SAUNA, NCT05701241: Continuing Somatostatin Analogues Upon Progression in Neuroendocrine Tumour pAtients

Recruiting
4
270
Europe
Somatostatin analog, lanreotide, octreotide, sandostatin, somatuline
University Hospital, Antwerp, Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Belgium Health Care Knowledge Centre
Gastroenteropancreatic Neuroendocrine Tumor
04/29
04/34
BALLAD, NCT04257461: A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma

Active, not recruiting
3
30
Europe
Fluoropyrimidine, Capecitabine, LV5FU2, Oxaliplatin, Xeloda
Belgian Group of Digestive Oncology, Kom Op Tegen Kanker, Cancer Research UK
Small Bowel Adenocarcinoma
12/25
12/25
NCT03464305 / 2017-001397-41: ASPIRIN Trial Belgium

Active, not recruiting
3
148
Europe
acetylsalicylic acid, Placebo
University Hospital, Antwerp, Kom Op Tegen Kanker, Anticancerfund
Colon Cancer
12/27
12/27
NCT04735900: lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Recruiting
N/A
60
Europe
Liquid biopsy sampling
University Hospital, Antwerp, Amgen
Metastatic Colorectal Cancer
03/22
03/22
NALIRI, NCT05095064: Retrospective Study on the Efficacy and Tolerability of Liposomal Irinotecan

Active, not recruiting
N/A
60
Europe
Onivyde® + 5-FULV, Nanoliposomal irinotecan
University Hospital, Antwerp, Universitair Ziekenhuis Brussel, AZ Nikolaas, General Hospital Groeninge, University Hospital St Luc, Brussels, ASZ Aalst, Erasme University Hospital, Centre Hospitalier Universitaire de Liege, OLVZ Ziekenhuis Aalst
Metastatic Pancreatic Ductal Adenocarcinoma
03/22
03/22
NCT04641676: A Study to Examine the Value of Broad Agnostic Next Generation Sequencing (NGS) Panel Testing Versus Reimbursed Organ-directed NGS: a Belgian Precision Study of the BSMO in Collaboration With the Cancer Center

Recruiting
N/A
1000
Europe
NGS testing
The Belgian Society of Medical Oncology, Foundation Medicine, Sciensano, Roche Pharma AG
Metastatic Cancer, Local Tumor Invasion
09/22
12/22
REAL-V, NCT05033158: The Immune Reaction Upon COVID-19 Vaccination in the Belgian Cancer Population.

Completed
N/A
402
Europe
Blood sampling
University Hospital, Antwerp, KomOpTegenKanker (non-profit organization)
Cancer
12/22
06/23
MATTERS, NCT04467593: Safety Study of Whole Body Hyperthermia for Advanced Cancer

Recruiting
N/A
14
Europe
Whole body hyperthermia, Standard of Care (SOC) chemotherapy according to the NCCN guidelines.
ElmediX
Advanced Cancer, Pancreatic Cancer Metastatic
06/25
06/25

Download Options